Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cells
Year: 2022
Type: article
Abstract: Mutations in IDH1 and IDH2 drive the development of gliomas. These genetic alterations promote tumor cell renewal, disrupt differentiation states, and induce stem-like properties. Understanding how this phenotypic reprogramming occurs remains an area of high interest in glioma research. Previously, we showed that IDH mutation results in the development of a CD24-positive cell population in gliomas. Here, we demonstrate that this CD24-positive population possesses striking stem-like properties at the molecular and phenotypic levels. We found that CD24 expression is associated with stem-like features in IDH-mutant tumors, a patient-derived gliomasphere model, and a neural stem cell model of IDH1-mutant glioma. In orthotopic models, CD24-positive cells display enhanced tumor initiating potency compared to CD24-negative cells. Furthermore, CD24 knockdown results in changes in cell viability, proliferation rate, and gene expression that closely resemble a CD24-negative phenotype. Our data demonstrate that induction of a CD24-positive population is one mechanism by which IDH-mutant tumors acquire stem-like properties. These findings have significant implications for our understanding of the molecular underpinnings of IDH-mutant gliomas.
Source: Neoplasia
Institutions: Memorial Sloan Kettering Cancer Center, Cornell University, Weill Cornell Medicine, Cleveland Clinic, Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases, Shanghai Medical College of Fudan University, Fudan University, Rockefeller University, Case Western Reserve University
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,170
Awards: G2051006376, G289723095, Elucidating genetics of response to immune checkpoint blockade in lung cancer, Towards Precision Immuno-Oncology: Unraveling the Genomic Determinants and Mechanisms Underlying Immunotherapy Efficacy and Resistance, G9000003249, Cancer Center Support Grant, Cancer Biology Training Grant
OpenAlex ID: W4223505646
